Ask yourself this:
Is your RAP worth $160M without the technology?
And why did it fall to 7 cents and below?
Its the same issues with all Tech or Biotech companies - the question is: does the tech works?
Well, the clinical trials speak for themselves.
Just like similar results from RAP tests, which coincidentally caused its SP to take off. Without those results, RAP would be hovering around 7 cents as it was before the results of its tests.
Wednesday Outlook, page-24
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $34.28M | |||
| Open | High | Low | Value | Volume |
| 4.0¢ | 4.0¢ | 3.8¢ | $26.06K | 672.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 104334 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 230121 | 4 |
View Market Depth
| Last trade - 14.49pm 02/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |